125 related articles for article (PubMed ID: 36168721)
1. Plasminogen activating inhibitor-1 promotes angiogenesis in cutaneous angiosarcomas.
Ohuchi K; Amagai R; Ikawa T; Muto Y; Roh Y; Endo J; Maekawa T; Kambayashi Y; Asano Y; Fujimura T
Exp Dermatol; 2023 Jan; 32(1):50-59. PubMed ID: 36168721
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of TM5614 in combination with paclitaxel in the treatment of paclitaxel-resistant cutaneous angiosarcoma: Phase II study protocol.
Fujimura T; Yoshino K; Nakamura M; Kato H; Ito T; Maekawa T; Fujisawa Y; Matsushita S; Amagai R; Yamazaki E; Takahashi M; Tamabuchi E; Hashimoto A; Kambayashi Y; Yamazaki N; Miyata T; Asano Y
Exp Dermatol; 2024 Jan; 33(1):e14976. PubMed ID: 37946551
[TBL] [Abstract][Full Text] [Related]
3. Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts.
Wu Y; Zhang Q; Ann DK; Akhondzadeh A; Duong HS; Messadi DV; Le AD
Am J Physiol Cell Physiol; 2004 Apr; 286(4):C905-12. PubMed ID: 14644771
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer.
Kaneko T; Konno H; Baba M; Tanaka T; Nakamura S
Cancer Sci; 2003 Jan; 94(1):43-9. PubMed ID: 12708473
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.
Baker EA; Bergin FG; Leaper DJ
Mol Pathol; 2000 Dec; 53(6):307-12. PubMed ID: 11193049
[TBL] [Abstract][Full Text] [Related]
6. Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells.
van Hinsbergh VW; Vermeer M; Koolwijk P; Grimbergen J; Kooistra T
Blood; 1994 Nov; 84(9):2984-91. PubMed ID: 7949170
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.
Wojta J; Kaun C; Breuss JM; Koshelnick Y; Beckmann R; Hattey E; Mildner M; Weninger W; Nakamura T; Tschachler E; Binder BR
Lab Invest; 1999 Apr; 79(4):427-38. PubMed ID: 10211995
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 increases the expression of VEGF in human glioma cells.
Hjortland GO; Lillehammer T; Somme S; Wang J; Halvorsen T; Juell S; Hirschberg H; Fodstad Ø; Engebraaten O
Exp Cell Res; 2004 Mar; 294(1):130-9. PubMed ID: 14980508
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of vascular endothelial growth factor, urokinase plasminogen activator and plasminogen activator inhibitor-1 in node-negative breast cancer.
Meo S; Dittadi R; Peloso L; Gion M
Int J Biol Markers; 2004; 19(4):282-8. PubMed ID: 15646834
[TBL] [Abstract][Full Text] [Related]
11. Irradiation-induced angiosarcoma and anti-angiogenic therapy: a therapeutic hope?
Azzariti A; Porcelli L; Mangia A; Saponaro C; Quatrale AE; Popescu OS; Strippoli S; Simone G; Paradiso A; Guida M
Exp Cell Res; 2014 Feb; 321(2):240-7. PubMed ID: 24384475
[TBL] [Abstract][Full Text] [Related]
12. Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner.
Maillard C; Jost M; Rømer MU; Brunner N; Houard X; Lejeune A; Munaut C; Bajou K; Melen L; Dano K; Carmeliet P; Fusenig NE; Foidart JM; Noel A
Neoplasia; 2005 Jan; 7(1):57-66. PubMed ID: 15720817
[TBL] [Abstract][Full Text] [Related]
13. Intracellular Expression of PAI-1 Specific Aptamers Alters Breast Cancer Cell Migration, Invasion and Angiogenesis.
Fortenberry YM; Brandal SM; Carpentier G; Hemani M; Pathak AP
PLoS One; 2016; 11(10):e0164288. PubMed ID: 27755560
[TBL] [Abstract][Full Text] [Related]
14. Vascular-targeted agents for the treatment of angiosarcoma.
Young RJ; Woll PJ; Staton CA; Reed MW; Brown NJ
Cancer Chemother Pharmacol; 2014 Feb; 73(2):259-70. PubMed ID: 24253175
[TBL] [Abstract][Full Text] [Related]
15. Insulin enhances vascular endothelial growth factor, interleukin-8, and plasminogen activator inhibitor 1 but not interleukin-6 release by human adipocytes.
Fain JN; Madan AK
Metabolism; 2005 Feb; 54(2):220-6. PubMed ID: 15690317
[TBL] [Abstract][Full Text] [Related]
16. Expression of the proteolytic factors, tPA and uPA, PAI-1 and VEGF during malignant glioma progression.
Sandström M; Johansson M; Sandström J; Bergenheim AT; Henriksson R
Int J Dev Neurosci; 1999; 17(5-6):473-81. PubMed ID: 10571409
[TBL] [Abstract][Full Text] [Related]
17. Irradiation-induced regulation of plasminogen activator inhibitor type-1 and vascular endothelial growth factor in six human squamous cell carcinoma lines of the head and neck.
Artman T; Schilling D; Gnann J; Molls M; Multhoff G; Bayer C
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):574-82. PubMed ID: 20117293
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer.
Mashiko S; Kitatani K; Toyoshima M; Ichimura A; Dan T; Usui T; Ishibashi M; Shigeta S; Nagase S; Miyata T; Yaegashi N
Cancer Biol Ther; 2015; 16(2):253-60. PubMed ID: 25587663
[TBL] [Abstract][Full Text] [Related]
19. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells.
Feener EP; Northrup JM; Aiello LP; King GL
J Clin Invest; 1995 Mar; 95(3):1353-62. PubMed ID: 7883982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]